SCHEMBL16181925

SCHEMBL16181925

COC(C(=O)NCC1=CC=C(Cl)C(Nc2nc3cc(Cl)c(N4CCCC(C(F)(F)F)C4)cc3n2C)C1)(c1ccccc1)C(F)(F)F

nearest known ligand 0.47

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
PTGES O14684 20/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9939989 0.83 PTGES (0.50) PTGES
SCHEMBL9939853 0.72 PTGES (0.72) PTGES
SCHEMBL9939828 0.71 PTGES (0.80) PTGES
SCHEMBL9939858 0.71 PTGES (0.73) PTGES
SCHEMBL9939850 0.71 PTGES (0.80) PTGES
SCHEMBL9939925 0.71 PTGES (0.71) PTGES
SCHEMBL9939932 0.71 PTGES (0.71) PTGES
SCHEMBL9939921 0.70 PTGES (0.72) PTGES
SCHEMBL9939873 0.70 PTGES (0.54) PTGES
SCHEMBL9899133 0.70 PTGES (0.67) PTGES

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2649052-B1 2-AMINOBENZIMIDAZOLE DERIVATIVES USEFUL IN THE TREATMENT OF INFLAMMATION BOEHRINGER INGELHEIM INT (DE) 2014-10-22 EP disclosed